相关实验视频
Updated: May 2, 2026

08:28
Experimental Metastasis Assay
Published on: August 25, 2010
20.3K
促进以价值为基础的实验室医学:迈向临床实验室创新模式
Mario Plebani1, Abdurrahman Coskun2
1Department of Medicine-DIMED, University of Padova, Italy.
概括
临床实验室必须采用基于价值的实验室医学 (VBLM),使用个性化数据,专注于患者的福祉,而不仅仅是效率. 这种转变确保了客观的解释,并强调了实验室专业人员在现代医疗保健中的关键作用.
科学领域:
- 实验室医学 实验室医学
- 医疗保健管理的管理
- 临床病理学 临床病理学
背景情况:
- 医疗保健行业正在向基于价值的模式过渡,优先考虑质量和结果而不是数量.
- 临床实验室在适应这些新的基于价值的支付模式时面临挑战和机遇.
- 目前对实验室数据的解释往往是主观的,阻碍了实验室价值的证明.
研究的目的:
- 倡导采用基于价值的实验室医学 (VBLM).
- 用可测量的变量促进实验室数据的客观解释.
- 强调实验室专业人员和数据在医疗保健中的重要作用.
主要方法:
- 从主观的数据解释转向客观的数据解释.
- 使用纵向数据进行个性化参考区间 (pRI),个性化决策限值 (pDL) 和个性化参考变化值 (pRCV).
- 通过利用实验室数据进行健康监测,将重点从"病情护理"转移到"健康护理".
- 实施综合实践单元,而不是传统的"工厂"模型.
主要成果:
- 实验室信息的客观解释可以通过可测量的变量和个性化指标来实现.
- 纵向数据分析可以将原始实验室数据转化为可操作的临床见解.
- 实验室数据对于监测健康个体和患者的健康状况至关重要,支持"健康护理"方法.
- 采用综合实践单位提高了临床实验室在更广泛的医疗保健系统中的价值和影响.
结论:
- 基于价值的实验室医学 (VBLM) 需要转向客观,个性化的数据解释.
- 实验室专业人员必须主动推动采用个性化指标和综合实践模型.
- 临床实验室对于支持向积极主动,以结果和质量为重点的"健康护理"系统过渡至关重要.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
12.8K
05:13Author Spotlight: Advancing Therapeutic Strategies for Improving Pregnancy Rates by Analyzing Embryo-Endometrium Interactions
Published on: June 21, 2024
1.9K
相关概念视频
In-vitro Mutagenesis
14.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K